Ingredion secures $1.475B term loan for Tate & Lyle acquisition, replaces bridge tranche

Filed June 25, 2026 · Period ending June 24, 2026 · ~1 min read

Key Changes

• high

  Ingredion entered a $1.475B delayed draw term loan facility with JPMorgan to fund its acquisition of Tate & Lyle PLC, structured as $500M 3-year and $975M 5-year tranches with 5% annual amortization.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• high

  The new facility replaces the $1.475B tranche A of Ingredion's previously announced $4.225B bridge loan from June 8, leaving $2.75B in bridge commitments outstanding.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• high

  Loan proceeds will fund cash consideration for all Tate & Lyle shares, refinance Tate & Lyle's existing debt, and cover transaction costs, with currency hedging required to convert dollars to sterling.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →